Idexx Labs’ Salesforce Integration Highlights Solid Quarter

Idexx Laboratories posted solid third-quarter results that fell squarely within expectations. The firm has made progress in its remodeling of its salesforce structure to a new configuration that makes it easier for customers to interact with a single point of access at Idexx, and we expect this reorganization should manifest itself in further growth over…

Read More

Steel Dynamics Delivers Strong Sequential Growth in Quarter

In the third quarter of 2013, Steel Dynamics delivered improved sequential operating results. Companywide operating income increased 64% to $113 million in the third quarter from a base of $69 million in the second quarter. While shipment volume increased across nearly every product line, steel operating income per ton increased to $94, which amounts to…

Read More

Dupont Meets Expectations but Chemicals Business Struggles

On Tuesday, DuPont reported third-quarter results that generally matched our expectations. DuPont experienced year-over-year operating earnings improvement in all of its segments except performance chemicals. We’re raising our fair value estimate to $57 per share from $55 to account for slight modifications to our forecast and the effect of the time value of money since…

Read More

Baxter Third Quarter Results On Track to Meet Full Year Guidance

Baxter reported third-quarter results that put it on track to meet our $4.68 adjusted EPS estimate for the year, slightly ahead of management guidance of $4.65-$4.67. We’re maintaining our $80 fair value estimate despite branded hemophilia and generic anesthesia and chemotherapy competition that will likely begin to emerge as headwinds in early 2014. We think…

Read More
Home